MARTINSRIED, Germany, Dec. 3, 2007 (PRIME NEWSWIRE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment) yesterday announced the formation of one of the most comprehensive strategic alliances in the discovery and development of biopharmaceuticals with Novartis. The deal is aimed at establishing a pipeline of innovative drugs, and combines MorphoSys's and Novartis's research, development, manufacturing and commercialization capabilities.
In order to provide detailed information on this announcement the Management Board of MorphoSys AG will host a public conference call and live audio webcast on Monday, December 03, 2007 at 10:00 CET.
Dial-in number: +49 (0)69 9897 2623 (listen-only) UK residents: +44 (0)20 7138 0844 Confirmation code: 8460477
The call will be hosted by:
Dr. Simon Moroney, Chief Executive Officer Dave Lemus, Chief Financial Officer
MorphoSys AG offers participants the opportunity to follow the presentation through a simultaneous slide presentation online at http://www.morphosys.com
The presentation slides will be available on the Company's website.
A slide-synchronized audio replay of the conference will be available following the live event on http://www.morphosys.com/conferencecalls.